Online: Renegade Research 'Research Roundtable', T cell dysfunction in ME/CFS seminar, May 23rd 2024

https://twitter.com/user/status/1788923517968265346


Our next @RenegadeRes Research roundtable is Thursday May 23rd. The topic is "T-cell dysfunction in #MECFS and #LongCovid " with researchers Liisa K. Selin, MD PhD; Anna Gil, PhD, viral immunologists from the University of Massachusetts Chan Medical School Roshan Kumar, PhD,… Show more


https://www.remissionbiome.org/events/calendar

 

Question.

What is Remission Biome’s role in this? I don’t get it.

 

Can’t remember which but I think renegade research is “run by” remission biome, or the other way around.

 

Yeah but they are the group telling people they have a secret treatment protocol with antibiotics.

 

Yeah I’m not saying I endorse them. Just that that might explain why this renegade research seminar includes remission biome.

 

On now

 

Came on late—she is promoting “inspiratol” maybe I should log off?

 

As far as i know that drug is supposed to decrease inflammation through the microbiome. On ME-pedia it says atleast 2 different clinical trials have been started but none published, I wonder if they will be published in future or it was found to be ineffective.

Given there are no published findings on it, them promoting the drug seems dodgy to me.

 

If it ducks like a quack, there is a high chance...

 

We have a thread on inspiritol

A member did post a pic of a duck.

 

I’m saving that picture it’s gold, thanks for bringing it up

 

I wasn’t really happy with that talk with everyone hyping that likely bogus inspiritol thing.

 

It sounds like bottled NLP.

 

From the Massachusetts ME/CFS & FM Association newsletter:
https://massmecfs.org/component/civicrm/?task=civicrm/mailing/view&id=1385&reset=1

Hear Massachusetts Researchers Talk About T-Cell Dysfunction in ME/CFS and Long COVID
Hosted by Research Renegade/Remission Biome, this roundtable took place on May 24, 2024.

Speakers: Liisa K. Selin, MD, PhD, and Anna Gil, PhD, viral immunologists from the Univ. of Massachusetts Chan Medical School, and Roshan Kumar, PhD, HiFiBiO Therapeutics, a clinical stage global biotech company in Cambridge, MA. These two Massachusetts research teams are working together on a project awarded by the Patient-Led Research Collaborative (PLRC). Also joining are PLRC Patient Representatives Megan L. Fitzgerald, PhD, and Rivka Solomon, MS.

Watch the video here.

 

Longer post I found on this:
T-cell dysfunction in ME/CFS and Long Covid

(Recorded on May 23, 2024)



Video now available

https://www.youtube.com/watch?v=e2FzJ6Md7hE

SPEAKERS

Liisa K. Selin, MD PhD; Anna Gil, PhD, viral immunologists from the University of Massachusetts Chan Medical School (liisa.selin@umassmed.edu and Anna.Gil@umassmed.edu)

Roshan Kumar, PhD, Executive Director, External Innovation, HiFiBiO Therapeutics (r.kumar@hifibio.com)

Megan Fitzgerald and Rivka Solomon, Patient-Led Research Collaborative (PLRC) patient representatives with the above two labs



ABOUT THE ROUNDTABLE



The Selin Lab is a viral immunology lab at UMass Chan focused on understanding human adaptive immune response and T cell response in multiple neuroinflammatory and infection-associated chronic illnesses, such as ME/CFS, long COVID and multiple sclerosis.



HiFiBiO is a clinical stage global biotech company focused on enhancing the probability of success for immunotherapies through its Drug Intelligence Science (DIS®) translational platform.



HiFiBiO and the Selin Lab are working together on a research project awarded by the Patient-Led Research Fund, a project of Patient-Led Research Collaborative (PLRC) and funded by Balvi. HiFiBiO is utilizing its single cell profiling capabilities to analyze samples from Long COVID and ME/CFS patients. Together with the SelinLab, their goal is to acquire deep insights into underlying immune mechanisms of these illnesses and understand the diversity in the patient population that could lead to potential diagnostic biomarkers and therapeutic innovations.



In this roundtable, the Selin Lab also discusses their new paper: Identification of CD8 T-cell dysfunction associated with symptoms in ME/CFS and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series. Paper found here: https://rb.gy/zl5iey



More info about the HiFiBiO-Selin Lab collaboration: https://rb.gy/mrqhgk and https://rb.gy/w91qef